Gennex Laboratories [GENNEX] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Gennex Laboratories Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gennex Laboratories Ltd. wins in 9 metrics, Innova Captab Ltd. wins in 10 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gennex Laboratories Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 14.37 31.20 Gennex Laboratories Ltd.
Price-to-Book Ratio 1.19 4.05 Gennex Laboratories Ltd.
Debt-to-Equity Ratio 39.79 32.95 Innova Captab Ltd.
PEG Ratio -7.90 1.33 Innova Captab Ltd.
EV/EBITDA 16.60 20.49 Gennex Laboratories Ltd.
Profit Margin (TTM) 12.59% 8.85% Gennex Laboratories Ltd.
Operating Margin (TTM) 13.54% 12.88% Gennex Laboratories Ltd.
EBITDA Margin (TTM) 13.54% 12.88% Gennex Laboratories Ltd.
Return on Equity 9.31% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 7.08% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-197.44M $-1.09B Gennex Laboratories Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return -15.32% -3.19% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 1.68 2.76 Gennex Laboratories Ltd.
Enterprise Value $3.08B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 2.03 2.90 Gennex Laboratories Ltd.
Gross Profit Margin (TTM) 29.90% 35.19% Innova Captab Ltd.
Revenue per Share (TTM) $6 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $0.73 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.60 -0.33 Innova Captab Ltd.

Gennex Laboratories Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

GENNEX
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gennex Laboratories Ltd.-1.42%-5.86%9.27%3.17%-21.03%-24.98%
Innova Captab Ltd.-0.63%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gennex Laboratories Ltd.-15.32%75.15%88.92%58.41%864.75%897.46%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Gennex Laboratories Ltd. vs Innova Captab Ltd.

MetricGENNEXINNOVACAP
Market Information
Market Cap i₹2.50B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i401,772578,151
90 Day Avg. Volume i626,792217,693
Last Close₹11.08₹857.00
52 Week Range₹7.05 - ₹17.25₹622.00 - ₹1,020.70
% from 52W High-35.77%-16.04%
All-Time High₹29.00 (Sep 16, 2024)₹1,260.00 (Jan 06, 2025)
% from All-Time High-61.79%-31.98%
Growth Metrics
Quarterly Revenue Growth0.07%0.42%
Quarterly Earnings Growth0.13%0.23%
Financial Health
Profit Margin (TTM) i0.13%0.09%
Operating Margin (TTM) i0.14%0.13%
Return on Equity (TTM) i0.09%0.13%
Debt to Equity (MRQ) i39.7932.95
Cash & Liquidity
Book Value per Share (MRQ)₹8.78₹178.28
Cash per Share (MRQ)₹1.98₹10.22
Operating Cash Flow (TTM) i₹-75,467,000₹282.88M
Levered Free Cash Flow (TTM) i₹181.23M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend i₹0.00₹2.00

Valuation & Enterprise Metrics Analysis: Gennex Laboratories Ltd. vs Innova Captab Ltd.

MetricGENNEX (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i14.3731.20
Forward P/E iN/A21.90
PEG Ratio i-7.901.33
Price to Sales (TTM) i1.682.76
Price to Book (MRQ) i1.194.05
Market Capitalization
Market Capitalization i₹2.50B₹41.43B
Enterprise Value i₹3.08B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i2.032.90
Enterprise to EBITDA i16.6020.49
Risk & Other Metrics
Beta i0.60-0.33
Book Value per Share (MRQ) i₹8.78₹178.28

Financial Statements Comparison: Gennex Laboratories Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENNEX (2025)INNOVACAP (2025)
Revenue/Sales i1.38B12.34B
Cost of Goods Sold i982.23M8.38B
COGS % of Revenue i71.4%67.9%
Gross Profit i393.29M3.96B
Gross Margin i28.6%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i147.25M1.65B
Operating Margin i10.7%13.4%
EBITDA i271.66M2.00B
EBITDA Margin i19.7%16.2%
Pre-Tax Income i215.47M1.71B
Pre-Tax Income % of Revenue i15.7%13.9%
Income Tax i32.75M427.58M
Income Tax % of Revenue i2.4%3.5%
Net Income (Profit) i181.23M1.28B
Profit Margin i13.2%10.4%

Balance Sheet & Liquidity Metrics

MetricGENNEX (2025)INNOVACAP (2025)
Cash & Equivalents i545.89M155.19M
Total Current Assets i1.81B7.03B
Total Current Assets % of Revenue i131.7%57.0%
Total Current Liabilities i445.55M3.53B
Total Current Liabilities % of Revenue i32.4%28.6%
Long-Term Debt i168.93M2.45B
Long-Term Debt % of Revenue i12.3%19.8%
Total Shareholders Equity i1.95B9.59B
Retained Earnings i562.59M4.53B
Retained Earnings % of Revenue i40.9%36.7%
Property, Plant & Equipment i88.69M442.93M

Cash Flow Statement Comparison

MetricGENNEX (2025)INNOVACAP (2025)
Operating Cash Flow i-75.47M282.88M
Operating Cash Flow % of Revenue i-5.5%2.3%
Capital Expenditures i-87.47M-1.72B
Free Cash Flow i-197.44M-1.09B
FCF Margin i-14.4%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGENNEXINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i242.95M57.22M
Float Shares i156.62M15.91M
% Held by Insiders i33.66%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i66.34%8.59%

Dividend Analysis & Yield Comparison: Gennex Laboratories Ltd. vs Innova Captab Ltd.

MetricGENNEXINNOVACAP
Last 12-Month Dividend i₹0.00₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend i₹0.00₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends i₹0.00₹2.00
Ex-Dividend DateN/AJan 30, 2026